YARW — Yarrow Bioscience, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1566044 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2020 | 3,269,000 | 2,898,000 | 23,491,000 | 24,714,000 | 93,742,000 | 57,563,000 | 56,249,000 |
| Dec 2019 | 0 | 0 | 23,199,000 | 23,161,000 | 81,159,000 | 43,759,000 | 63,584,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-73,503,000
Investing CF
—
Financing CF
$99,854,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-08-02
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 501,000 | -43,637,000 | -39,834,000 | 66,905,000 | 14,819,000 | — | — |
| Dec 2019 | — | 15,884,000 | 0 | 81,159,000 | 63,584,000 | — | — |
TTM Snapshot
Revenues TTM
$6,538,000
NetIncome TTM
$95,750,000
OpCashFlow TTM
$0
Assets (Latest)
$93,742,000
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.02T | $1148.84 | — |
| JNJ | JOHNSON & JOHNSON | $617.78B | $256.35 | — |
| ABBV | AbbVie Inc. | $443.36B | $250.94 | — |
| MRK | Merck & Co., Inc. | $321.57B | $130.20 | — |
| NVSEF | NOVARTIS AG | $301.30B | $158.52 | — |
News headlines (Yahoo Finance, 1h cache)
Recent Insider Activity
No insider activity indexed for this ticker.